Publicaciones en colaboración con investigadores/as de Leiden University Medical Center (6)

2022

  1. Gender differences in antithrombotic treatment in patients with atrial fibrillation from Spain versus the rest of Western Europe. GLORIA-AF Program

    Medicina Clinica, Vol. 159, Núm. 4, pp. 177-182

2021

  1. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433

2019

  1. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 8, pp. 618-628

2018

  1. Alirocumab and cardiovascular outcomes after acute coronary syndrome

    New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107

2017

  1. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

    Journal of the American College of Cardiology, Vol. 69, Núm. 7, pp. 777-785

2008

  1. Endothelial protein C receptor polymorphisms and risk of myocardial infarction

    Haematologica, Vol. 93, Núm. 9, pp. 1358-1363